PD-L1 抗体 (Extracellular Domain) (Biotin)
Quick Overview for PD-L1 抗体 (Extracellular Domain) (Biotin) (ABIN6992233)
抗原
See all PD-L1 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- Extracellular Domain
-
纯化方法
- PD-L1 Antibody is supplied as protein A purified IgG1.
-
免疫原
- PD-L1 antibody was raised against the extracellular domain of human PD-L1.
-
亚型
- IgG1
-
-
-
-
应用备注
- PD-L1 antibody can be used for as detection antibody in Sandwich Elisa at 1 μ,g/mL.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- PD-L1 Antibody is supplied in PBS containing 1 % BSA and 0.02 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,4 °C
-
储存方法
- PD-L1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- PD-L1 (CD274 (PD-L1))
-
别名
- PDL1
-
背景
- PD-L1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC) (1). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC (2). PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells (3). This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. PD-L1 also functions as an immune checkpoint protein, and multiple anti-PD-L1 antibodies are currently in phase II and III clinical trials, with one antibody already approved for the treatment of cancer (4).
-
基因ID
- 29126
-
NCBI登录号
- NP_054862
-
UniProt
- Q9NZQ7
-
途径
- Cancer Immune Checkpoints
抗原
-